Evidence map›Paper›PMID 29638228›Full record

ArticlePediatric research2018

Vascular endothelial growth factor accelerates compensatory lung growth by increasing the alveolar units.

Duy T Dao, Prathima Nandivada, Jacqueline T Vuong, Lorenzo Anez-Bustillos, Amy Pan, Hiroko Kishikawa, Paul D Mitchell, Meredith A Baker, Gillian L Fell, Thomas Martin and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Molecular Hydrogen in the Treatment of Respiratory Diseases.International journal of molecular sciences · 2025
    Review
  4. Blood flow-induced angiocrine signals promote organ growth and regeneration.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Alveologenesis: What Governs Secondary Septa Formation.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Duy T DaoVascular Biology Program and Department of Surgery, Boston Children's Hospital, Boston, Massachusetts.
Prathima NandivadaVascular Biology Program and Department of Surgery, Boston Children's Hospital, Boston, Massachusetts.
Jacqueline T VuongVascular Biology Program and Department of Surgery, Boston Children's Hospital, Boston, Massachusetts.
Lorenzo Anez-BustillosVascular Biology Program and Department of Surgery, Boston Children's Hospital, Boston, Massachusetts.
Amy PanVascular Biology Program and Department of Surgery, Boston Children's Hospital, Boston, Massachusetts.
Hiroko KishikawaVascular Biology Program and Department of Surgery, Boston Children's Hospital, Boston, Massachusetts.
Paul D MitchellInstitutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, Massachusetts.
Meredith A BakerVascular Biology Program and Department of Surgery, Boston Children's Hospital, Boston, Massachusetts.
Gillian L FellVascular Biology Program and Department of Surgery, Boston Children's Hospital, Boston, Massachusetts.
Thomas MartinPulmonary Function Laboratory, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
Mark PuderVascular Biology Program and Department of Surgery, Boston Children's Hospital, Boston, Massachusetts.
Boston Children's Hospital · US

Funding

HARVARD-LONGWOOD RESEARCH TRAINING IN VASCULAR SURGERYT32HL007734 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FERRAN, CHRISTIANE, LOGERFO, FRANK W · 1993 to 2023
$10.5M
Harvard-Longwood Short-Term Research Training in Vascular SurgeryT35HL110843 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CHRISTIANE FERRAN, FRANK W LOGERFO · 2013 to 2026
$609k
Generation and use of lipid emulsions to understand mechanisms of and optimally manage parenteral nutrition associated liver diseaseF32DK104525 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI FELL, GILLIAN LYNAPP · 2014 to 2016
$163k
NHLBI NIH HHS T32 HL007734NHLBI NIH HHS T35 HL110843NIDDK NIH HHS F32 DK104525NIDDK NIH HHS L40 DK106831
6 · The paper itself

Abstract

BackgroundDeficiency of vascular endothelial growth factor (VEGF) is associated with hypoplastic lung diseases, such as congenital diaphragmatic hernia. Provision of VEGF has been demonstrated to be beneficial in hyperoxia-induced bronchopulmonary dysplasia, and hence could induce lung growth and improve the outcome in hypoplastic lung diseases. We aimed to determine the effects of exogenous VEGF in a rodent model of compensatory lung growth after left pneumonectomy.MethodsEight-to-ten-week-old C57Bl6 male mice underwent left pneumonectomy, followed by daily intra-peritoneal injections of saline or VEGF (0.5 mg/kg). Lung volume measurement, pulmonary function tests, and morphometric analyses were performed on post-operative day (POD) 4 and 10. The pulmonary expression of angiogenic factors was analyzed by quantitative polymerase chain reaction and western blot.ResultsLung volume on POD 4 was higher in the VEGF-treated mice (P=0.03). On morphometric analyses, VEGF increased the parenchymal volume (P=0.001), alveolar volume (P=0.0003), and alveolar number (P<0.0001) on POD 4. The VEGF group displayed higher levels of phosphorylated-VEGFR2/VEGFR2 (P=0.03) and epidermal growth factor (EGF) messenger RNA (P=0.01).ConclusionVEGF accelerated the compensatory lung growth in mice, by increasing the alveolar units. These changes may be mediated by VEGFR2 and EGF-dependent mechanisms.

Indexed as

AnimalsBronchopulmonary DysplasiaEpidermal Growth FactorHyperoxiaLungMaleMiceMice, Inbred C57BLNeovascularization, PhysiologicOrganogenesisOrgan SizePneumonectomyPulmonary AlveoliVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Epidermal Growth FactorKdr protein, mouseVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouseVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID29638228
PMCPMC6019135
OpenAlexW2797937027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.